Patent ID: 11951189
Assignee: CLARITY PHARMACEUTICALS LTD
Field: Pharmaceuticals (Chemistry)
Classification: CPC A  C | IPC A  C

Claim 8:
9. A method of radioimaging a tumour or cancer in a subject, the method comprising the steps of:
i) administering to the subject a compound that can bind to a tumour or cancer site and comprises a functional group that reacts with a tetrazine moiety;
ii) allowing the unbound fraction of the compound administered in step i) to clear from the subject;
iii) administering to the subject a compound of Formula (I) according to claim 1, where the compound is complexed with a radioisotope selected from the group consisting of 60Cu, 61Cu, 64Cu and 67Cu; and
iv) radioimaging the tumour or cancer site, wherein the functional group of the compound that can bind to a tumour or cancer site that reacts with a tetrazine moiety further comprises a transcyclooctene group.